My Watchlist

Top Indices

Nasdaq Composite

SPX

My Portfolio

iShares Biotechnology ETF (NQ:IBB)

168.77 -0.12 (-0.07%)

Official Closing Price Updated: 4:15 PM EST, Dec 31, 2025 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about iShares Biotechnology ETF

< Previous 1 2

...

8 9 10 11 12 13 14 15 16

...

27 28 Next >

Did ARKK Bottom? ↗

July 05, 2022

ARKK may be the most extraordinary example of sheer brilliance and horrific money management combined.

Via Talk Markets

3 Biotech Stocks to Sell Now ↗

July 05, 2022

These biotech stocks remain vulnerable to more downside. Their charts remain broken and resistance looms ominously overhead.

Via InvestorPlace

The Daily Biotech Pulse: AstraZeneca Goes Shopping, TYME Technologies & Syros Pharma Merger, FDA Clears Vertex Pharma's Stem Cell-Based Diabetes Therapy Study ↗

July 05, 2022

Here's a roundup of top developments in the biotech space over the last 24 hours:

Via Benzinga

Something Still Smells. Actions You Should Take Now! ↗

July 03, 2022

In June alone, the S&P 500, the Dow, the Nasdaq 100, and the Small-Cap indices were all down over 8% for the month. It wasn't pretty. Fortunately, it's halftime, and this can create an opportunity for...

Via Talk Markets

What’s Next For Biotech And Healthcare ↗

June 13, 2022

Biotechs have sold off this year along with the broader market. Declines have been more pronounced than prior pullbacks. However, healthcare continues to outperform.

Via Talk Markets

Growth and Inflation Fears May Have Peaked: Top Trading Opportunities ↗

July 01, 2022

As bad as US equity markets have been in 2022, Chinese equity markets have had it much worse since early 2021.

Via Talk Markets

The Daily Biotech Pulse: FDA Wants Omicron-Targeted COVID-19 Boosters, Provention Bio Clears Hits Hurdle For Diabetes Prevention Drug, Oxford Biomedica, AstraZeneca Strike Vaccine Pact ↗

July 01, 2022

Here's a roundup of top developments in the biotech space over the last 24 hours:

Via Benzinga

Attention Biotech Investors: Mark Your Calendar For These July PDUFA Dates ↗

July 01, 2022

The biotech sector is poised to end June on a positive note, despite largely disappointing regulatory decisions scheduled during the month, thanks to a reversal in broader market sentiment.

Via Benzinga

The Daily Biotech Pulse: Pfizer/BioNTech Ink New COVID-19 Vaccine Supply Pact, Sanofi Hit By FDA Clinical Hold, Angion Biomedica Halts Second Kidney Disease Trial ↗

June 30, 2022

Here's a roundup of top developments in the biotech space over the last 24 hours:

Via Benzinga

Post PCE-What is the Pre-PCE Market Saying? ↗

June 29, 2022

Stocks are primarily unchanged or trading slightly higher as pressures from rising food and energy prices persist.

Via Talk Markets

The Daily Biotech Pulse: Eli Lilly Modifies COVID-19 Treatment Pact, Oyster Point Outlines Restructuring Plan, Icosavax Posts Interim RSV Vaccine Data ↗

June 29, 2022

Here's a roundup of top developments in the biotech space over the last 24 hours:

Via Benzinga

The Daily Biotech Pulse: Kezar Life Surges On Positive Kidney Disease Trial Data, FDA Rejects Spero Therapeutics' Tebipenem, Graybug Reviews Strategic Alternatives ↗

June 28, 2022

Here's a roundup of top developments in the biotech space over the last 24 hours:

Via Benzinga

Flu Shots Can Cut Down Risk Of Alzheimer's, Exploratory Study Finds ↗

June 28, 2022

Alzheimer's is a tough neurological disease to tackle, given the difficulty in diagnosing at an early stage, and the limited and effective treatment options currently available.

Via Benzinga

The Daily Biotech Pulse: CHMP Backs AstraZeneca's Breast Cancer Therapies, Ipsen Buys Epizyme, FDA Holds For Nuvation Bio, Astellas Studies ↗

June 27, 2022

Here's a roundup of top developments in the biotech space over the last 24 hours:

Via Benzinga

7 Biotech Stocks With Key Catalysts Coming in July ↗

June 27, 2022

Biotech stocks have had a rocky few months, but many are on the mend. These picks should provide investors both flexibility and growth.

Via InvestorPlace

The Daily Biotech Pulse: European Backing For Novavax's COVID-19 Shot In Adolescents, Sanofi-GSK's Updated Vaccine Effective Against Omicron, FDA's Clinical Hold On Sarepta's Duchenne Trial ↗

June 24, 2022

Here's a roundup of top developments in the biotech space over the last 24 hours:

Via Benzinga

The Daily Biotech Pulse: F-Star Therapeutics Buyout, Orphan Drug Tag For VBI's Brain Cancer Vaccine, Xenon's Epilepsy Candidate Shows Promise ↗

June 23, 2022

Here's a roundup of top developments in the biotech space over the last 24 hours:

Via Benzinga

Are We Heading Towards Recession? ↗

June 22, 2022

Transportation, as the ultimate demand indicator, could also help us determine the fate of recession.

Via Talk Markets

The Daily Biotech Pulse: Precision BioSciences Inks Gene Editing Pact, Athira Pharma's Alzheimer's Candidate Fails, Enanta Sues Pfizer Over COVID-19 Antiviral ↗

June 22, 2022

Here's a roundup of top developments in the biotech space over the last 24 hours:

Via Benzinga

Demand Destruction as Seen in the Transportation Sector ↗

June 21, 2022

Transportation IYT opened higher, ran to its 200-week moving average, and retreated, albeit whilst remaining green on the day.

Via Talk Markets

The Daily Biotech Pulse: Thumbs Down For Acadia's Pimavanserin, Pfizer Buys Stake In Valneva, AstraZeneca - Ionis Eplontersen Aces Rare Disease Trial ↗

June 21, 2022

Here's a roundup of top developments in the biotech space over the last 24 hours:

Via Benzinga

A Moment Of Truth - Ways To Help You Deal With A New Reality ↗

June 19, 2022

The truth can be difficult to hear. This week, investors had to deal with a heavy dose of truth about the state of the economy. Based on the markets’ response, it was painfully unexpected and...

Via Talk Markets

The Daily Biotech Pulse: Addex Terminates Parkinson's Study, Expanded Use Of Rhythm's Obesity Drug, FDA Approval For AbbVie's Skyrizi In Crohn's Disease ↗

June 17, 2022

Here's a roundup of top developments in the biotech space over the last 24 hours:

Via Benzinga

The Daily Biotech Pulse: Roche's Alzheimer's Drug Fails, Advisors Back Pfizer, Moderna Shots For Youngest Kids, Valneva Settles COVID-19 Pact With UK ↗

June 16, 2022

Here's a roundup of top developments in the biotech space over the last 24 hours:

Via Benzinga

Can the Fed Control Inflation with Higher Rates? ↗

June 15, 2022

Today’s rally in equities might be met with further selling very soon once the market realizes that the Fed cannot go far enough.

Via Talk Markets

The Daily Biotech Pulse: FDA Committee Backs Moderna Shot For 5-17 Years, 180 Life Sciences Stock Plunges, Pfizer's Posts Disappointing Paxlovid Data ↗

June 15, 2022

Here's a roundup of top developments in the biotech space over the last 24 hours:

Via Benzinga

For Signs of a Relief Rally, Watch the S&P 500 v. Retail ↗

June 14, 2022

With inflation on everyone’s lips and the price of gas and food showing no signs of abating, the retail sector is the key to assessing where the equity market goes from here.

Via Talk Markets

The Daily Biotech Pulse: FDA Nod For Lilly-Incyte's Patchy Hair Loss Treatment, First Regulatory Submission For EQRx, Soleno's Promising Data From Prader-Willi Candidate ↗

June 14, 2022

Here's a roundup of top developments in the biotech space over the last 24 hours:

Via Benzinga

Why This Biotech ETF May Be About to Break Out ↗

June 09, 2022

There’s a chance shares of the iShares Biotechnology ETF (NASDAQ: IBB) may be about to break out. They are testing a resistance level. If they can get above it, a new uptrend may form.

Via Benzinga

Watch For The Nasdaq 100 and S&P 500 to Clear Their Mini Ranges ↗

June 08, 2022

As the current leader of the major indices, IWM has been playing a very important role in the overall market direction.

Via Talk Markets

< Previous 1 2

...

8 9 10 11 12 13 14 15 16

...

27 28 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.